You are here

Article info

Article menu
Download PDFPDF
Concise reports
Hydroxychloroquine treatment for primary Sjögren’s syndrome: its effect on salivary and serum inflammatory markers

Authors

  1. Professor M Tishler, Department of Rheumatology, Tel Aviv-Souraski Medical Center, Ichilov Hospital, 6 Weizmann Street, Tel Aviv 64239, Israel.
View Full Text

Citation

Tishler M, Yaron I, Shirazi I, et al
Hydroxychloroquine treatment for primary Sjögren’s syndrome: its effect on salivary and serum inflammatory markers
Annals of the Rheumatic Diseases 1999;58:253-256.

Publication history

  • Accepted January 18, 1999
  • First published April 1, 1999.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Annals of the Rheumatic Diseases